[1]
E. Sarıyıldız, “Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry”, Acta Medica, vol. 55, no. 3, pp. 215–222, Sep. 2024.